Summary
Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report on April 23, 2026, to announce its financial results for the fiscal quarter ended March 28, 2026. The press release detailing these results is furnished as an exhibit to this filing. Investors should refer to the attached Exhibit 99.1 for the complete financial performance and operational details of the company during this period. While this 8-K primarily serves to furnish the earnings release, it's crucial for investors to review the information provided in Exhibit 99.1 to understand TMO's recent performance, any forward-looking statements made, and management's commentary on key business drivers and financial condition. The filing itself does not contain extensive new information beyond referencing the earnings announcement.
Key Highlights
- 1Thermo Fisher Scientific (TMO) released its financial results for the fiscal quarter ended March 28, 2026.
- 2The official earnings press release is furnished as Exhibit 99.1 to the 8-K filing.
- 3Investors are directed to Exhibit 99.1 for detailed financial and operational performance.
- 4The filing indicates the event date and filing date were both April 23, 2026.
- 5Information furnished in this report is not considered 'filed' for Section 18 of the Exchange Act purposes unless specifically referenced in other filings.
- 6The report includes the Cover Page Interactive Data File in its exhibits.